31 Jul 2009 16:02
Immunodiagnostic Systems Holdings plc
Annual General Meeting
Immunodiagnostic Systems Holdings plc ("the Company"), a leading producer of diagnostic testing kits for the clinical and research markets, held its annual General Meeting ("AGM") earlier today.
The Board of the Company is pleased to announce that shareholders approved all resolutions proposed at the Company's AGM.
At the meeting, David Evans, the Company's Chairman, announced that trading for the Company continues to be in-line with management expectations and that it remains optimistic for the outcome for the financial year as a whole to 31 March 2010.
Enquiries:
| Immunodiagnostic Systems Holdings Plc | Tel: 0191 519 0660 |
| Roger Duggan, CEO | |
| Paul Hailes, Finance Director | |
| Brewin Dolphin Investment Banking | Tel: 0845 213 4730 |
| Andrew Emmott Sean Wyndham-Quin | |
| Walbrook PR Ltd | Tel: 020 7933 8787 |
| Paul McManus | Mob: 07980 541 893 |
| paul.mcmanus@walbrookpr.com |